Abstract:Background Polymerase chain reaction (PCR) is an important means by which to study the urine microbiome and is emerging as possible alternative to urine cultures to identify pathogens that cause urinary tract infection (UTI). However, PCR is limited by its inability to differentiate DNA originating from viable, metabolically active versus non-viable, inactive bacteria. This drawback has led to concerns that urobiome studies and PCR-based diagnosis of UTI are confounded by the presence of relic DNA from non-viable bacteria in urine. Propidium monoazide (PMA) dye can penetrate cells with compromised cell membranes and covalently bind to DNA, rendering it inaccessible to amplification by PCR. Although PMA has been shown to differentiate between non-viable and viable bacteria in various settings, its effectiveness in urine has not been previously studied. We sought to investigate the ability of PMA to differentiate between viable and non-viable bacteria in urine. Methods Varying amounts of viable or non-viable uropathogenic E. coli (UTI89) or buffer control were titrated with mouse urine. The samples were centrifuged to collect urine sediment or not centrifuged. Urine samples were incubated with PMA and DNA cross-linked using blue LED light. DNA was isolated and uidA gene-specific PCR was performed. For in vivo studies, mice were inoculated with UTI89, followed by ciprofloxacin treatment or no treatment. After the completion of ciprofloxacin treatment, an aliquot of urine was plated on non-selective LB agar and another aliquot was treated with PMA and subjected to uidA-specific PCR. Results PMA’s efficiency in excluding DNA signal from non-viable bacteria was significantly higher in bacterial samples in phosphate-buffered saline (PBS, dC T =13.69) versus bacterial samples in unspun urine (dC T =1.58). This discrepancy was diminished by spinning down urine-based bacterial samples to collect sediment and resuspending it in PBS prior to PMA treatment. In 3 of 5 replicate groups of UTI89-infected mice, no bacteria grew in culture; however, there was PCR amplification of E. coli after PMA treatment in 2 of those 3 groups. Conclusion We have successfully developed PMA-based PCR methods for amplifying DNA from live bacteria in urine. Our results suggest that non-PMA bound DNA from live bacteria can be present in urine, even after antibiotic treatment. This indicates that viable but non-culturable E. coli can be present following treatment of UTI, and may explain why some patients have persistent symptoms but negative urine cultures following UTI treatment.

Dead reckoning of protist viability with propidium monoazide (PMA)-quantitative PCR; a case study using Neoparamoeba perurans

Propidium Monoazide Pretreatment on a 3D-Printed Microfluidic Device for Efficient PCR Determination of ‘liveversusdead’ Microbial Cells

Propidium monoazide is unreliable for quantitative live-dead molecular assays

Method to detect only viable cells in microbial ecology

Detection of Viable Bacterium Cells Based on Propidium Monoazide in Combination with PCR

Propidium monoazide treatment to distinguish between live and dead methanogens in pure cultures and environmental samples

Quantification of Viable Bacteria in Wastewater Treatment Plants by Using Propidium Monoazide Combined with Quantitative PCR (Pma-Qpcr)

A Novel Propidium Monoazide-Based PCR Assay Can Measure Viable Uropathogenic E. coli In Vitro and In Vivo

Application of Propidium Monoazide Quantitative Real-Time PCR to Quantify the Viability of Lactobacillus Delbrueckii Ssp. Bulgaricus

Development of PMA-qPCR Assay to Accurately and Reproducible Quantify Viable Bacteria of Paenibacillus Polymyxa.

Influence of propidium monoazide (PMA) on detection of Listeria mono-cytogenes in food

Quantitative study of viable Vibrio parahaemolyticus cells in raw seafood using propidium monoazide in combination with quantitative PCR

Isolation of Mitochondrial Cytochrome B Gene and Development of A Real-Time Quantitative Pcr Assay for Detecting Neoparamoeba Aestuarina

Revealing the Viable Microbial Community of Biofilm in a Sewage Treatment System Using Propidium Monoazide Combined with Real-Time PCR and Metagenomics

Quantitative real-time PCR combined with propidium monoazide for the selective quantification of viable periodontal pathogens in an in vitro subgingival biofilm model

Optimization, validation, and application of a real-time PCR protocol for quantification of viable bacterial cells in municipal sewage sludge and biosolids using reporter genes and Escherichia coli

Enumeration of Vibrio Parahaemolyticus in VBNC State by PMA-combined Real-Time Quantitative PCR Coupled with Confirmation of Respiratory Activity

Rapid Detection of Live E. Coli O157:H7 by PMA-qPCR Method

Propidium Monoazide-Treated, Cell-Direct, Quantitative PCR for Detecting Viable Chloramphenicol-Resistant Escherichia coli and Corynebacterium glutamicum Cells

An Optimized Method to Assess Viable Escherichia coli O157:H7 in Agricultural Soil Using Combined Propidium Monoazide Staining and Quantitative PCR

[Evaluation of Pathogen Disinfection Efficacy by Chlorine and Monochloramine Disinfection Based on Quantitative PCR Combined with Propidium Monoazide (Pma-Qpcr)].